Why the study?
Does iohexol reduce the frequency of side effects compared to high-osmolar ionic compounds in patients undergoing venography for suspected DVT?
Does iohexol reduce the frequency of side effects compared to high-osmolar ionic compounds in patients undergoing venography for suspected DVT?
Iohexol for venography is associated with minor side effects in about 20% of patients, but serious adverse reactions are rare and overall side effects are significantly less frequent than with high-osmolar contrast agents.
Answers are grounded in this paper and cite their sources.
Supports iohexol for venography with rare serious reactions; extends prior observational data showing fewer side effects than high-osmolar agents.
The frequency of side effects of a nonionic contrast agent (iohexol) was studied in 463 consecutive patients who underwent venography for clinically suspected deep-vein thrombosis (DVT) and compared with the frequency of adverse reactions of another series in which patients received either the same contrast material or a high-osmolar ionic compound. Minor side effects, including local pain and discomfort, nausea and vomiting, dizziness, skin reactions, superficial phlebitis, and edema, occurred in 83 patients (17.9%; 95% confidence interval [CI], 15%-22%). The only serious adverse reaction (bronchospasm) was seen in two patients (0.4%; 95% CI, 0.1%-1.4%). Postvenographic thrombosis confirmed by means of repeat venography occurred in one of 41 consecutive patients with a previous normal venogram (incidence, 2%; 95% CI, 0%-13%). The frequency of side effects appears to be significantly less than when conventional high-osmolar contrast agents are used. Use of iohexol for venography is associated with minor side effects in approximately one-fifth of patients, and serious adverse reactions necessitating therapy are rare.
No takes yet. Share an insight, caveat, or question.
Lensing et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: